Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AmDen Pharmaceuticals Denmark ApS
APS
Active
CVR 42045403
Vandværksvej 5
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2021
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK -8K
-4% vs 2024
EBITDA margin
100.0%
+4% vs 2024
Equity ratio
58.5%
Financial strength
Net profit 2025
DKK -5K
+35% vs 2024
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
1M
2021
0M
-100%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK -8K
-4%
EBITDA
DKK -8K
+4%
Net profit
DKK -5K
+35%
Total assets
DKK 31K
-15%
Equity
DKK 18K
-21%
Employees
—
—
Company information
Legal name
AmDen Pharmaceuticals Denmark ApS
CVR number
42045403
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
15. januar 2021
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 direktører i forening.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Vandværksvej 5
Phone
+4560155843
Email
flemmingdyremose@amphade.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Stevns
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
750
-7
-5
-8
-8
Staff expenses
-0
-0
-0
-0
-0
EBITDA
750
-7
-5
-8
-8
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
750
-7
-5
-8
-8
Net financials
-2
-10
-2
-1
1
Profit before tax
748
-17
-7
-9
-7
Tax
165
-2
-2
-1
-2
Net profit
584
-15
-5
-8
-5
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
795
42
37
36
31
Equity
624
35
30
23
18
Long-term debt
0
0
0
0
0
Short-term debt
172
7
7
13
13
Total debt
172
7
7
13
13
Financial ratios
5-year trend
EBITDA margin
-751400.0%
This company
15.8%
Market median
-4755796% vs market
2021
2025
Equity ratio
58.5%
This company
38.2%
Market median
+53% vs market
2021
2025
Return on equity
-27.3%
This company
18.4%
Market median
-248% vs market
2021
2025
Net profit margin
-490700.0%
This company
8.1%
Market median
-6058125% vs market
2021
2025
Asset turnover
-0.24×
This company
1.12×
Market median
-121% vs market
2021
2025
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-15 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
MS
Mikael Søndergaard Thomsen
Management
Management
2021
FD
Flemming Dyremose
Management
Management
2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Flandy Holding ApS
Company
50–66.65%
50–66.65%
2021
Thomsen Pharma ApS
Company
50–66.65%
50–66.65%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Thomsen Pharma ApS
AmDen Pharmaceuticals Denmark ApS
(this company)
Board network connections
Board members of AmDen Pharmaceuticals Denmark ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mikael Søndergaard Thomsen
Management
0 companies
Flemming Dyremose
Management
0 companies